Literature DB >> 23560829

Premalignant conditions of gastric cancer.

Kentaro Sugano1.   

Abstract

Premalignant lesions of gastric cancer encompass a variety of conditions such as chronic gastritis, intestinal metaplasia and dysplasia, in which elevated risk of developing gastric cancer have been documented. Among them, intestinal metaplasia is frequently encountered in our daily endoscopic examination, yet its clinical significance is often underestimated despite of a number of reports demonstrating genetic and epigenetic alterations in the intestinal metaplastic mucosa. In this review, I will describe the molecular mechanisms of phenotypic changes from gastric mucosa to intestinal metaplasia based on our analysis of mouse model of intestinal metaplasia generated by ectopic expression of CDX2 in conjunction with the studies with human intestinal metaplasia.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23560829     DOI: 10.1111/jgh.12209

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

Review 1.  Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.

Authors:  Juanita L Merchant; Milena Saqui-Salces
Journal:  Cancer Treat Rev       Date:  2013-08-13       Impact factor: 12.111

2.  AKT plays a crucial role in gastric cancer.

Authors:  Takamitsu Sasaki; Yuichi Yamashita; Hiroki Kuniyasu
Journal:  Oncol Lett       Date:  2015-05-25       Impact factor: 2.967

3.  Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.

Authors:  Alessandro Franchi; Annarita Palomba; Lucia Miligi; Valentina Ranucci; Duccio Rossi Degli Innocenti; Antonella Simoni; Monica Pepi; Marco Santucci
Journal:  Virchows Arch       Date:  2014-11-28       Impact factor: 4.064

4.  Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.

Authors:  Bo Gun Jang; Byung Lan Lee; Woo Ho Kim
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

Review 5.  Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.

Authors:  Mohamed Abozeid; Antonio Rosato; Roberta Sommaggio
Journal:  Biomed Res Int       Date:  2017-07-11       Impact factor: 3.411

Review 6.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

7.  Association between pro-(IL-8) and anti-inflammatory (IL-10) cytokine variants and their serum levels and H. pylori-related gastric carcinogenesis in northern India.

Authors:  Sushil Kumar; Niraj Kumari; Rama Devi Mittal; Samir Mohindra; Uday C Ghoshal
Journal:  Meta Gene       Date:  2015-08-26

8.  Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process.

Authors:  Da Hyun Jung; Jie-Hyun Kim; Yong Chan Lee; Sang Kil Lee; Sung Kwan Shin; Jun Chul Park; Hyun Soo Chung; Hyunki Kim; Hoguen Kim; Yong Hoon Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park
Journal:  J Gastric Cancer       Date:  2015-12-31       Impact factor: 3.720

9.  Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.

Authors:  Seung Hwan Shin; Da Hyun Jung; Jie-Hyun Kim; Hyun Soo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

10.  Performance of a Multiplex Serological Helicobacter pylori Assay on a Novel Microfluidic Assay Platform.

Authors:  Angela Filomena; Anna Guenther; Hannes Planatscher; Francois Topin; Joseph She; Luca Formichella; Laurent Terradot; Markus Gerhard; Thomas O Joos; Hannelore Meyer; Nicole Schneiderhan-Marra
Journal:  Proteomes       Date:  2017-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.